NCT00003927View on ClinicalTrials.gov

Combination Chemotherapy, Amifostine, and Peripheral Stem Cell Transplantation in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

May 18, 1999

Primary Completion Date

March 21, 2023

Study Completion Date

March 21, 2023

Conditions
Breast Cancer
Interventions
BIOLOGICAL

filgrastim

DRUG

amifostine trihydrate

DRUG

cyclophosphamide

DRUG

doxorubicin hydrochloride

DRUG

paclitaxel

PROCEDURE

peripheral blood stem cell transplantation

Trial Locations (1)

91010-3000

Cancer Center and Beckman Research Institute, City of Hope, Duarte

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER